日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aurora A kinase as a target for therapy in TCF3-HLF rearranged acute lymphoblastic leukemia

Aurora A 激酶作为 TCF3-HLF 重排急性淋巴细胞白血病的治疗靶点

Leonard, Jessica; Wolf, Joelle Sj; Degnin, Michelle; Eide, Christopher A; LaTocha, Dorian; Lenz, Kyle; Wilmot, Beth; Mullighan, Charles G; Loh, Mignon; Hunger, Stephen P; Druker, Brian J; Loriaux, Marc M; Tyner, Jeffrey W; Chang, Bill H

SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia

SYK抑制可阻断BAFF-B细胞受体串扰,从而拮抗慢性淋巴细胞白血病中的Mcl-1。

Paiva, Cody; Rowland, Taylor A; Sreekantham, Bhargava; Godbersen, Claire; Best, Scott R; Kaur, Prabhjot; Loriaux, Marc M; Spurgeon, Stephen E F; Danilova, Olga V; Danilov, Alexey V

Therapeutically Targetable ALK Mutations in Leukemia

白血病中可治疗靶向的ALK突变

Maxson, Julia E; Davare, Monika A; Luty, Samuel B; Eide, Christopher A; Chang, Bill H; Loriaux, Marc M; Tognon, Cristina E; Bottomly, Daniel; Wilmot, Beth; McWeeney, Shannon K; Druker, Brian J; Tyner, Jeffrey W

A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor.

将 Idelalisib 与新型脾酪氨酸激酶 (Syk) 抑制剂 GS-9973 联合使用,有望成为治疗慢性淋巴细胞白血病的潜在疗法

Burke Russell T, Meadows Sarah, Loriaux Marc M, Currie Kevin S, Mitchell Scott A, Maciejewski Patricia, Clarke Astrid S, Dipaolo Julie A, Druker Brian J, Lannutti Brian J, Spurgeon Stephen E

Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML

慢性中性粒细胞白血病和非典型慢性粒细胞白血病中的致癌性 CSF3R 突变

Maxson, Julia E; Gotlib, Jason; Pollyea, Daniel A; Fleischman, Angela G; Agarwal, Anupriya; Eide, Christopher A; Bottomly, Daniel; Wilmot, Beth; McWeeney, Shannon K; Tognon, Cristina E; Pond, J Blake; Collins, Robert H; Goueli, Basem; Oh, Stephen T; Deininger, Michael W; Chang, Bill H; Loriaux, Marc M; Druker, Brian J; Tyner, Jeffrey W

Comparison of methods to identify aberrant expression patterns in individual patients: augmenting our toolkit for precision medicine

比较识别个体患者异常表达模式的方法:扩充我们的精准医疗工具包

Bottomly, Daniel; Ryabinin, Peter A; Tyner, Jeffrey W; Chang, Bill H; Loriaux, Marc M; Druker, Brian J; McWeeney, Shannon K; Wilmot, Beth

HitWalker: variant prioritization for personalized functional cancer genomics

HitWalker:用于个性化功能性癌症基因组学的变异优先级排序

Bottomly, Daniel; Wilmot, Beth; Tyner, Jeffrey W; Eide, Christopher A; Loriaux, Marc M; Druker, Brian J; McWeeney, Shannon K

MET receptor sequence variants R970C and T992I lack transforming capacity

MET受体序列变体R970C和T992I缺乏转化能力

Tyner, Jeffrey W; Fletcher, Luke B; Wang, Ellen Q; Yang, Wayne F; Rutenberg-Schoenberg, Michael L; Beadling, Carol; Mori, Motomi; Heinrich, Michael C; Deininger, Michael W; Druker, Brian J; Loriaux, Marc M